Titre : Tumeurs de la plèvre

Tumeurs de la plèvre : Questions médicales fréquentes

Termes MeSH sélectionnés :

Exercise
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Tumeurs de la plèvre : Questions médicales les plus fréquentes", "headline": "Tumeurs de la plèvre : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Tumeurs de la plèvre : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-05-29", "dateModified": "2025-02-23", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Tumeurs de la plèvre" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Tumeurs de l'appareil respiratoire", "url": "https://questionsmedicales.fr/mesh/D012142", "about": { "@type": "MedicalCondition", "name": "Tumeurs de l'appareil respiratoire", "code": { "@type": "MedicalCode", "code": "D012142", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C08.785" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Mésothéliome malin", "alternateName": "Mesothelioma, Malignant", "url": "https://questionsmedicales.fr/mesh/D000086002", "about": { "@type": "MedicalCondition", "name": "Mésothéliome malin", "code": { "@type": "MedicalCode", "code": "D000086002", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C08.785.640.350" } } }, { "@type": "MedicalWebPage", "name": "Épanchement pleural malin", "alternateName": "Pleural Effusion, Malignant", "url": "https://questionsmedicales.fr/mesh/D016066", "about": { "@type": "MedicalCondition", "name": "Épanchement pleural malin", "code": { "@type": "MedicalCode", "code": "D016066", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C08.785.640.700" } } } ], "about": { "@type": "MedicalCondition", "name": "Tumeurs de la plèvre", "alternateName": "Pleural Neoplasms", "code": { "@type": "MedicalCode", "code": "D010997", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Najib M Rahman", "url": "https://questionsmedicales.fr/author/Najib%20M%20Rahman", "affiliation": { "@type": "Organization", "name": "Oxford Centre for Respiratory Medicine, Churchill Hospital, Oxford, UK; Nuffield Department of Medicine, University of Oxford, Oxford, UK." } }, { "@type": "Person", "name": "Kevin G Blyth", "url": "https://questionsmedicales.fr/author/Kevin%20G%20Blyth", "affiliation": { "@type": "Organization", "name": "School of Cancer Sciences, University of Glasgow, Glasgow, UK; Queen Elizabeth University Hospital, Glasgow, UK; Cancer Research UK Scotland Centre, Glasgow, UK. Electronic address: kevin.blyth@glasgow.ac.uk." } }, { "@type": "Person", "name": "None None", "url": "https://questionsmedicales.fr/author/None%20None", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Michele Mondoni", "url": "https://questionsmedicales.fr/author/Michele%20Mondoni", "affiliation": { "@type": "Organization", "name": "Respiratory Unit, ASST Santi Paolo e Carlo, Department of Health Sciences, Università degli Studi di Milano, 20122 Milan, Italy." } }, { "@type": "Person", "name": "Giampietro Marchetti", "url": "https://questionsmedicales.fr/author/Giampietro%20Marchetti", "affiliation": { "@type": "Organization", "name": "Pulmonology Unit, ASST Spedali Civili, 25123 Brescia, Italy." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "The intensity of a resistance exercise session can be quantified by the work rate of exercise.", "datePublished": "2023-10-05", "url": "https://questionsmedicales.fr/article/37797065", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1371/journal.pone.0291857" } }, { "@type": "ScholarlyArticle", "name": "Exercise to Treat Hypertension: Late Breaking News on Exercise Prescriptions That FITT.", "datePublished": "2022-08-01", "url": "https://questionsmedicales.fr/article/35946847", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1249/JSR.0000000000000983" } }, { "@type": "ScholarlyArticle", "name": "Intelligent Estimation of Exercise Induced Energy Expenditure Including Excess Post-Exercise Oxygen Consumption (EPOC) with Different Exercise Intensity.", "datePublished": "2023-11-16", "url": "https://questionsmedicales.fr/article/38005621", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/s23229235" } }, { "@type": "ScholarlyArticle", "name": "Ischemic Preconditioning, But Not Priming Exercise, Improves Exercise Performance in Trained Rock Climbers.", "datePublished": "2023-08-22", "url": "https://questionsmedicales.fr/article/37607294", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1519/JSC.0000000000004565" } }, { "@type": "ScholarlyArticle", "name": "Outcomes following supervised exercise and home-based exercise for patients with intermittent claudication.", "datePublished": "2022-10-04", "url": "https://questionsmedicales.fr/article/36435597", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jvn.2022.09.006" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Maladies de l'appareil respiratoire", "item": "https://questionsmedicales.fr/mesh/D012140" }, { "@type": "ListItem", "position": 3, "name": "Tumeurs de l'appareil respiratoire", "item": "https://questionsmedicales.fr/mesh/D012142" }, { "@type": "ListItem", "position": 4, "name": "Tumeurs de la plèvre", "item": "https://questionsmedicales.fr/mesh/D010997" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Tumeurs de la plèvre - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Tumeurs de la plèvre", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-08", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Tumeurs de la plèvre", "description": "Comment diagnostique-t-on une tumeur de la plèvre ?\nQuels tests sont utilisés pour le mésothéliome ?\nLes marqueurs tumoraux sont-ils utiles ?\nQuels symptômes indiquent une tumeur pleurale ?\nL'imagerie par résonance magnétique est-elle nécessaire ?", "url": "https://questionsmedicales.fr/mesh/D010997?mesh_terms=Exercise&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Tumeurs de la plèvre", "description": "Quels sont les symptômes courants des tumeurs pleurales ?\nLa douleur thoracique est-elle fréquente ?\nPeut-on avoir des symptômes sans tumeur visible ?\nLes symptômes varient-ils selon le type de tumeur ?\nLes symptômes peuvent-ils s'aggraver rapidement ?", "url": "https://questionsmedicales.fr/mesh/D010997?mesh_terms=Exercise&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Tumeurs de la plèvre", "description": "Peut-on prévenir les tumeurs de la plèvre ?\nQuels facteurs de risque sont associés ?\nLe tabagisme influence-t-il le risque ?\nY a-t-il des vaccins pour prévenir ces tumeurs ?\nComment réduire l'exposition à l'amiante ?", "url": "https://questionsmedicales.fr/mesh/D010997?mesh_terms=Exercise&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Tumeurs de la plèvre", "description": "Quels traitements sont disponibles pour les tumeurs pleurales ?\nLa chirurgie est-elle toujours nécessaire ?\nLa chimiothérapie est-elle efficace contre le mésothéliome ?\nQuels sont les effets secondaires des traitements ?\nLa radiothérapie est-elle utilisée en palliatif ?", "url": "https://questionsmedicales.fr/mesh/D010997?mesh_terms=Exercise&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Tumeurs de la plèvre", "description": "Quelles complications peuvent survenir ?\nLes tumeurs pleurales peuvent-elles se propager ?\nComment gérer la douleur liée aux tumeurs ?\nY a-t-il un risque d'infection ?\nLes complications affectent-elles le pronostic ?", "url": "https://questionsmedicales.fr/mesh/D010997?mesh_terms=Exercise&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Tumeurs de la plèvre", "description": "Quels sont les principaux facteurs de risque ?\nL'âge influence-t-il le risque de tumeurs pleurales ?\nLes antécédents médicaux jouent-ils un rôle ?\nLe sexe influence-t-il le risque ?\nLes conditions environnementales affectent-elles le risque ?", "url": "https://questionsmedicales.fr/mesh/D010997?mesh_terms=Exercise&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostique-t-on une tumeur de la plèvre ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic se fait par imagerie (CT, IRM) et biopsie pour confirmer la nature de la tumeur." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour le mésothéliome ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests d'imagerie, des analyses de sang et des biopsies sont utilisés pour le mésothéliome." } }, { "@type": "Question", "name": "Les marqueurs tumoraux sont-ils utiles ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains marqueurs comme le CA-125 peuvent aider à diagnostiquer les tumeurs pleurales." } }, { "@type": "Question", "name": "Quels symptômes indiquent une tumeur pleurale ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des douleurs thoraciques, une toux persistante et des difficultés respiratoires peuvent indiquer une tumeur." } }, { "@type": "Question", "name": "L'imagerie par résonance magnétique est-elle nécessaire ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'IRM peut être utilisée pour évaluer l'extension des tumeurs pleurales, mais n'est pas toujours nécessaire." } }, { "@type": "Question", "name": "Quels sont les symptômes courants des tumeurs pleurales ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent douleur thoracique, toux, essoufflement et parfois fièvre." } }, { "@type": "Question", "name": "La douleur thoracique est-elle fréquente ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la douleur thoracique est un symptôme courant des tumeurs de la plèvre." } }, { "@type": "Question", "name": "Peut-on avoir des symptômes sans tumeur visible ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des symptômes peuvent apparaître même si la tumeur est petite ou difficile à détecter." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon le type de tumeur ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent varier selon qu'il s'agit d'une tumeur bénigne ou maligne." } }, { "@type": "Question", "name": "Les symptômes peuvent-ils s'aggraver rapidement ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains types de tumeurs pleurales peuvent provoquer une aggravation rapide des symptômes." } }, { "@type": "Question", "name": "Peut-on prévenir les tumeurs de la plèvre ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La prévention est difficile, mais éviter l'exposition à l'amiante peut réduire le risque." } }, { "@type": "Question", "name": "Quels facteurs de risque sont associés ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "L'exposition à l'amiante, le tabagisme et certaines conditions environnementales augmentent le risque." } }, { "@type": "Question", "name": "Le tabagisme influence-t-il le risque ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme augmente le risque de développer des tumeurs pleurales, surtout avec l'amiante." } }, { "@type": "Question", "name": "Y a-t-il des vaccins pour prévenir ces tumeurs ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Actuellement, il n'existe pas de vaccins spécifiques pour prévenir les tumeurs de la plèvre." } }, { "@type": "Question", "name": "Comment réduire l'exposition à l'amiante ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Évitez les lieux de travail à risque et suivez les réglementations de sécurité pour réduire l'exposition." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour les tumeurs pleurales ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent la chirurgie, la chimiothérapie et la radiothérapie selon le type de tumeur." } }, { "@type": "Question", "name": "La chirurgie est-elle toujours nécessaire ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Non, la chirurgie dépend de la taille et du type de la tumeur, ainsi que de l'état du patient." } }, { "@type": "Question", "name": "La chimiothérapie est-elle efficace contre le mésothéliome ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la chimiothérapie est souvent utilisée pour traiter le mésothéliome, mais son efficacité varie." } }, { "@type": "Question", "name": "Quels sont les effets secondaires des traitements ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Les effets secondaires peuvent inclure fatigue, nausées, et problèmes respiratoires selon le traitement." } }, { "@type": "Question", "name": "La radiothérapie est-elle utilisée en palliatif ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la radiothérapie peut être utilisée pour soulager les symptômes dans les cas avancés." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent l'accumulation de liquide pleural, la douleur chronique et la dyspnée." } }, { "@type": "Question", "name": "Les tumeurs pleurales peuvent-elles se propager ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les tumeurs pleurales peuvent se propager à d'autres parties du corps, notamment les poumons." } }, { "@type": "Question", "name": "Comment gérer la douleur liée aux tumeurs ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "La gestion de la douleur peut inclure des analgésiques, des traitements palliatifs et des interventions chirurgicales." } }, { "@type": "Question", "name": "Y a-t-il un risque d'infection ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les patients peuvent être à risque d'infections pulmonaires en raison de la maladie ou des traitements." } }, { "@type": "Question", "name": "Les complications affectent-elles le pronostic ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les complications peuvent aggraver le pronostic et influencer les options de traitement." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les principaux facteurs incluent l'exposition à l'amiante, le tabagisme et des antécédents familiaux." } }, { "@type": "Question", "name": "L'âge influence-t-il le risque de tumeurs pleurales ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le risque augmente avec l'âge, surtout chez les personnes exposées à des substances cancérigènes." } }, { "@type": "Question", "name": "Les antécédents médicaux jouent-ils un rôle ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents de maladies pulmonaires ou d'exposition à des agents cancérigènes augmentent le risque." } }, { "@type": "Question", "name": "Le sexe influence-t-il le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les hommes sont généralement plus à risque de développer des tumeurs pleurales que les femmes." } }, { "@type": "Question", "name": "Les conditions environnementales affectent-elles le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, vivre près d'industries polluantes ou d'anciens sites d'amiante augmente le risque." } } ] } ] }

Sources (10000 au total)

The intensity of a resistance exercise session can be quantified by the work rate of exercise.

Athletes regularly perform resistance training, yet it is unknown how best to monitor its intensity. This study compared different resistance exercise intensity metrics to determine their sensitivity ... Following baseline testing for 10- and 3-repetition maximum (RM; squat and bench press), fourteen trained participants completed four volume-matched protocols in a randomised order: 3x10 with 85% 10RM... Internal intensity and work-rate metrics were highest for 3x1060s, followed by 3x10180s, 8x3120s and 8x3300s (p≤0.027). TI and II were higher for 8x3 than 3x10 protocols (p<0.001), but not different w... Work rate corroborated objective internal intensity metrics during resistance exercise, with the highest work rate session (3x1060s) also eliciting greater RPE scores than other protocols. In contrast...

Outcomes following supervised exercise and home-based exercise for patients with intermittent claudication.

Intermittent claudication (IC) is the most common symptom of peripheral arterial disease (PAD) which presents as a consequence of muscle ischaemia resulting from the atherosclerotic obstruction to art... Retrospective data were analysed to examine walking and ABPI outcomes for participants who completed a 12-week course of supervised or home-based exercise. All participants had a history of IC.... 46 participants (mean age 69±11 years; 76% male; 29% current smokers) referred for exercise were assessed, completed a 12-week course of exercise (home-based or supervised) and subsequently attended f... A 12-week course of supervised exercise results in significantly greater walking distance outcomes (COD and PWD) than unmonitored home-based exercise. In contrast with previous findings (Lane et al. 2... A 12-week programme of exercise favourably influenced walking and ABPI outcomes for patients with IC. Both home-based exercise and supervised individualised exercise increased walking distances, but t...

Physiological adaptations following vigorous exercise and moderate exercise with superimposed electrical stimulation.

Neuromuscular electrical stimulation (NMES) induces involuntary muscle contraction, preferentially promotes anaerobic metabolism, and is applicable for increasing exercise intensity. This study aimed ... Eight participants trained with a cycling ergometer at 100% of the ventilatory threshold (VT) (73.3% of peak oxygen consumption) (VOL), and another nine participants trained with the cycling ergometer... Rating of perceived exertion (RPE) in VOLES (12.00 ± 1.50) was significantly lower than in VOL (14.88 ± 1.81) (p < 0.05) during training sessions. Peak power output during the exercise tolerance test ... Our results suggest that both superimposing subtetanic NMES onto moderate-intensity voluntary exercise and vigorous voluntary intensity exercise induce the improvement in cardiovascular and metabolic ...

Relationship among subjective exercise experience, exercise behavior, and trait anxiety in adolescents.

To investigate the influence of subjective exercise experience on adolescent trait anxiety and to reveal the mediating effect of exercise behavior.... Using the Subjective Exercise Experience Scale (SEES), Physical Exercise Rating Scale (PARS-3), and Trait Anxiety Inventory (T-AI), a questionnaire survey was conducted among 500 adolescents in Southw... 1) Among adolescents, the exercise behavior of boys was significantly higher than that of girls (p < 0.05), and the subjective exercise experience of students aged 9 to 12 was significantly higher tha... The good subjective exercise experience not only has direct benefits for improving trait anxiety in adolescents but also helps to improve their exercise behavior, enrich daily physical exercise activi...